Navigation Links
BD and FIND Achieve Milestone in Global Battle Against MDR-TB
Date:6/17/2009

Price reductions for liquid culture tests will accelerate access to improved TB diagnostics

SEATTLE, June 17 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company; NYSE: BDX), a leading global medical technology company, and FIND (Foundation for Innovative New Diagnostics), a Swiss foundation that develops, evaluates and accelerates the implementation of new diagnostic tools for poverty-related diseases, today announced a significant price reduction in the cost of liquid culture testing.

The agreement lowers the cost of BD MGIT(TM) reagents. BD's TB diagnostic technologies utilize liquid culture, a key "standard of care" TB testing protocol that provides results far faster than traditional, solid media culture. The liquid culture test, widely used in modern research settings, is particularly effective for stemming the spread of multi-drug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) in developing countries.

"By collaborating with such leading global health organizations as FIND, BD's Global Health initiative implements diagnostic programs that help strengthen healthcare infrastructures in developing countries," said Krista Thompson, Vice President and General Manager, Global Health, BD. "With an emphasis on accessibility, affordability and sustainability, BD provides on-the-ground technical assistance, training and products that maximize the capacity to diagnose TB, including drug-resistant strains, in nations where the disease is most prevalent."

The price reduction -- announced five months earlier than anticipated -- arises from a November 2007 agreement between BD and FIND. At that time, BD agreed to reduce already below-market prices upon the completion of 3.5 million tests, a milestone achieved this month. The lower prices will enable more tests to be administer
'/>"/>

SOURCE BD (Becton, Dickinson and Company)
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
2. Pharsight Achieves First License Sale for Public-Source Database
3. GenoLogics Geneus Achieves GeneChip-compatible(TM) Status with the Affymetrix GeneChip(R) Microarray Platform
4. Sanofi Pasteurs Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage
5. Signalife Achieves $1.98 Million Sales Orders Thus Far
6. Australian Therapeutics Goods Administration Approval for ActiPatch Achieved
7. Korean Food and Drug Administration Approval for ActiPatch Achieved
8. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
9. UD researchers race ahead with latest spintronics achievement
10. Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
11. Dragon Announces R&D Achievement in Biotech Manufacturing Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Wellesley, Mass. (PRWEB) , ... September 02, 2015 ... ... that includes development of botanical and plant-derived compounds. BCC Research reveals in ... drugs past 2020 because this market defines the category and generates the most ...
(Date:9/2/2015)... Calif. , Sept. 2, 2015 Veracyte, ... Bonnie H. Anderson , president and chief executive officer, ... on Wednesday, September 16, 2015 at 10:30 a.m. ET ... The live audio webcast and subsequent replay ... The webcast will be available shortly after conclusion of ...
(Date:9/2/2015)... ... September 02, 2015 , ... Advancing ... high-risk surgeries. From vital sign monitoring in ICU to 3D skull printing analysis ... to make real-time clinical decisions with simultaneous access to high precision medical images ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... and life science research, today unveiled Genedata Screener ® version 13.0 at ... in-vitro screening brings to market a rich set of new capabilities. Screener now ...
Breaking Biology Technology:Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 3Veracyte to Present at Morgan Stanley Global Healthcare Conference 2Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 2Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 4
... Replidyne, Inc.,(Nasdaq: RDYN ) today announced its financial ... 2008., Replidyne reported a net loss of $18.7 million ... per basic and diluted common share of $0.69,per share, compared ... share or $1.65 per common share on a fully diluted ...
... Nexavar Net Sales increase 107% over Second Quarter 2007, ... ONXX ) today reported its financial results,for the ... reported net income,of $4.5 million, or $0.08 per diluted ... net loss of $10.8 million, or $0.22 per diluted ...
... Aug. 5 TriMix Laboratories LLC today,announced it ... Solutions,as the exclusive pharmacy for prescription fulfillment of ... as a first line and secondary,treatment for erectile ... compounding pharmacy which makes TriMix gel(TM) medicine for,each ...
Cached Biology Technology:Replidyne Announces Second Quarter 2008 Results From Operations 2Replidyne Announces Second Quarter 2008 Results From Operations 3Replidyne Announces Second Quarter 2008 Results From Operations 4Replidyne Announces Second Quarter 2008 Results From Operations 5Replidyne Announces Second Quarter 2008 Results From Operations 6Replidyne Announces Second Quarter 2008 Results From Operations 7Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 2Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 3Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 4Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 5Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 6Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 7Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 8Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 9Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 10TriMix Laboratories Announces New Partnership With American Pharmacy Solutions 2TriMix Laboratories Announces New Partnership With American Pharmacy Solutions 3
(Date:8/5/2015)... Aug. 5, 2015 The biosensors market is ... applications, penetration into newer sectors, and development of devices ... biosensors space has seen the entry of multiple participants ... far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... Analysis of the Global Biosensors Market ( http://www.frost.com/nee9 ...
(Date:8/4/2015)... (NASDAQ: AMRI ) today reported financial and operating results for ... , Second quarter contract revenue of $ 85.2 ... Adjusted contract margins of 26 % , ... in EPS from royalties in the current quarter , ... are very pleased to present another strong financial quarter, with all ...
(Date:7/31/2015)... 2015 Den 10. internationale konference om Genomik ... 22. - 25. oktober i Shenzhen ... fødselsdag i år. Siden starten i 2006 er ICB ... ,omik,-feltet, og er en af de mest dynamiske, entusiastiske ... på nylige gennembrud og fremskridt inden for ,omik,-forskning, som ...
Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2
... Überwachung drinnen und im Freien ... Solutions (WTS), ein technologisches Startup-Unternehmen aus Schweden, stellt ... Ein intelligentes, neues Gerät mit dazugehöriger App, das ... immer und von überall aus zu lokalisieren. Trax ...
... the Advancement of Science has announced that the Johns ... the Department of Biophysics and Biophysical Chemistry; Philip Cole, ... Sciences; Valina Dawson, Ph.D., of the Department of Neurology; ... the Henry A. Rowland Department of Physics and Astronomy ...
... Boulder, Colo., USA GSA Bulletin articles posted online ... Sinai-Negev erg of Egypt and Israel; petrology in the ... in the Central Andes of Argentina; sedimentology of the ... Tepetiltic, western Mexico; and thermochronology of the Appalachian Mountains. ...
Cached Biology News:Halten Sie Ihre Kinder und Haustiere mit TRAX im Auge - dem neuen, intelligenten GPS-Tracker 2Halten Sie Ihre Kinder und Haustiere mit TRAX im Auge - dem neuen, intelligenten GPS-Tracker 34 Johns Hopkins researchers named AAAS Fellows 2GSA Bulletin posts new studies from China, Egypt and Israel, Argentina, Mexico, California, Appalachia 2GSA Bulletin posts new studies from China, Egypt and Israel, Argentina, Mexico, California, Appalachia 3GSA Bulletin posts new studies from China, Egypt and Israel, Argentina, Mexico, California, Appalachia 4GSA Bulletin posts new studies from China, Egypt and Israel, Argentina, Mexico, California, Appalachia 5GSA Bulletin posts new studies from China, Egypt and Israel, Argentina, Mexico, California, Appalachia 6
Non-Protein Peroxidase Stabilizer , 1 L...
Component of GELase™ Agarose Gel-Digesting Preparation. 1 ml of 50X Buffer is sufficient for replacing the buffer in at least 5 g of gel....
RAT ANTI MOUSE METALLOPHILIC MACROPHAGES...
Request Info...
Biology Products: